These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Prevalence of treated patients with Alzheimer's disease: current trends and COVID-19 impact. Olazarán J; Carnero-Pardo C; Fortea J; Sánchez-Juan P; García-Ribas G; Viñuela F; Martínez-Lage P; Boada M Alzheimers Res Ther; 2023 Aug; 15(1):130. PubMed ID: 37537656 [TBL] [Abstract][Full Text] [Related]
8. Review of donepezil, rivastigmine, galantamine and memantine for the treatment of dementia in Alzheimer's disease in adults with Down syndrome: implications for the intellectual disability population. Prasher VP Int J Geriatr Psychiatry; 2004 Jun; 19(6):509-15. PubMed ID: 15211527 [TBL] [Abstract][Full Text] [Related]
9. [Current approaches to optimize treatment of dementia and Alzheimer's disease]. Kolykhalov IV Zh Nevrol Psikhiatr Im S S Korsakova; 2016; 116(6):87-92. PubMed ID: 28635795 [TBL] [Abstract][Full Text] [Related]
10. A meta-analysis of the efficacy of donepezil, rivastigmine, galantamine, and memantine in relation to severity of Alzheimer's disease. Di Santo SG; Prinelli F; Adorni F; Caltagirone C; Musicco M J Alzheimers Dis; 2013; 35(2):349-61. PubMed ID: 23411693 [TBL] [Abstract][Full Text] [Related]
12. Current treatments of Alzheimer disease: are main caregivers satisfied with the drug treatments received by their patients? Sevilla C; Jiménez Caballero PE; Alfonso V; González-Adalid M Dement Geriatr Cogn Disord; 2009; 28(3):196-205. PubMed ID: 19738386 [TBL] [Abstract][Full Text] [Related]
13. UK government guidance on Alzheimer's drugs postponed. O'Neill MF Drug Discov Today; 2005 Sep; 10(17):1132. PubMed ID: 16182201 [No Abstract] [Full Text] [Related]
14. Are cholinesterase inhibitors effective in the management of the behavioral and psychological symptoms of dementia in Alzheimer's disease? A systematic review of randomized, placebo-controlled trials of donepezil, rivastigmine and galantamine. Rodda J; Morgan S; Walker Z Int Psychogeriatr; 2009 Oct; 21(5):813-24. PubMed ID: 19538824 [TBL] [Abstract][Full Text] [Related]
15. [Current therapy of patients with dementia]. Fuchsberger T; Möller HJ; Hampel H MMW Fortschr Med; 2003 May; 145 Suppl 2():49-52, 54. PubMed ID: 14579485 [TBL] [Abstract][Full Text] [Related]
16. Ginkgo biloba compared with cholinesterase inhibitors in the treatment of dementia: a review based on meta-analyses by the cochrane collaboration. Kurz A; Van Baelen B Dement Geriatr Cogn Disord; 2004; 18(2):217-26. PubMed ID: 15237280 [TBL] [Abstract][Full Text] [Related]
17. Drug therapy of dementia in elderly patients. A review. Olsen CE; Poulsen HD; Lublin HK Nord J Psychiatry; 2005; 59(2):71-7. PubMed ID: 16195103 [TBL] [Abstract][Full Text] [Related]
18. [Medical treatment of Alzheimer's disease]. Johannsen P Ugeskr Laeger; 2006 Oct; 168(40):3424-9. PubMed ID: 17032609 [TBL] [Abstract][Full Text] [Related]
19. [Alzheimer dementia. Comparison of the effectiveness of cholinesterase inhibitors and gingko]. Gasser US; Gasser T MMW Fortschr Med; 2001 Dec; 143(51-52):40-1. PubMed ID: 11824165 [No Abstract] [Full Text] [Related]
20. Effective pharmacological management of Alzheimer's disease. Atri A Am J Manag Care; 2011 Nov; 17 Suppl 13():S346-55. PubMed ID: 22214392 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]